GALECTIN THERAPEUTICS INC. Basic Shares Outstanding (Weighted Average)
GALECTIN THERAPEUTICS INC. (GALT) reported Basic Shares Outstanding (Weighted Average) of 65.88 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 65.88M shares, a 3.83% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 65.78M shares, a 4.08% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 64.74M shares, a 3.18% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 64.20M shares, a 3.09% increase year-over-year.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 63.90M shares, a 2.56% increase from fiscal 2024.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 62.31M shares, a 3.57% increase from fiscal 2023.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 60.16M shares, a 1.29% increase from fiscal 2022.
- GALECTIN THERAPEUTICS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 59.39M shares, a 1.48% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 65.88M shares 10-Q · filed 2026-08-14 | 65.83M shares 10-Q · filed 2026-08-14 | 65.47M shares derived: average of 3 quarters · filed 2026-08-14 | 65.15M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 65.78M shares 10-Q · filed 2026-05-15 | 65.26M shares derived: average of 2 quarters · filed 2026-05-15 | 64.91M shares derived: average of 3 quarters · filed 2026-05-15 | 64.54M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 64.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 64.47M shares derived: average of 2 quarters · filed 2026-03-31 | 64.13M shares derived: average of 3 quarters · filed 2026-08-14 | 63.90M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 64.20M shares 10-Q · filed 2025-11-14 | 63.83M shares derived: average of 2 quarters · filed 2026-08-14 | 63.62M shares 10-Q · filed 2025-11-14 | 63.40M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 63.45M shares 10-Q · filed 2026-08-14 | 63.33M shares 10-Q · filed 2026-08-14 | 63.13M shares derived: average of 3 quarters · filed 2026-08-14 | 62.92M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 63.20M shares 10-Q · filed 2026-05-15 | 62.98M shares derived: average of 2 quarters · filed 2026-05-15 | 62.74M shares derived: average of 3 quarters · filed 2026-05-15 | 62.62M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 62.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 62.51M shares derived: average of 2 quarters · filed 2026-03-31 | 62.42M shares derived: average of 3 quarters · filed 2026-03-31 | 62.31M shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 62.28M shares 10-Q · filed 2025-11-14 | 62.26M shares derived: average of 2 quarters · filed 2025-11-14 | 62.16M shares 10-Q · filed 2025-11-14 | 62.09M shares derived: average of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 62.23M shares 10-Q · filed 2025-08-14 | 62.10M shares 10-Q · filed 2025-08-14 | 62.02M shares derived: average of 3 quarters · filed 2025-08-14 | 61.44M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 61.98M shares 10-Q · filed 2025-05-15 | 61.92M shares derived: average of 2 quarters · filed 2025-05-15 | 61.18M shares derived: average of 3 quarters · filed 2025-05-15 | 60.78M shares derived: average of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 61.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 60.78M shares derived: average of 2 quarters · filed 2025-03-31 | 60.38M shares derived: average of 3 quarters · filed 2025-03-31 | 60.16M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 59.70M shares 10-Q · filed 2024-11-14 | 59.64M shares derived: average of 2 quarters · filed 2024-11-14 | 59.59M shares 10-Q · filed 2024-11-14 | 59.55M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 59.58M shares 10-Q · filed 2024-08-13 | 59.53M shares 10-Q · filed 2024-08-13 | 59.50M shares derived: average of 3 quarters · filed 2024-08-13 | 59.47M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 59.48M shares 10-Q · filed 2024-05-15 | 59.45M shares derived: average of 2 quarters · filed 2024-05-15 | 59.43M shares derived: average of 3 quarters · filed 2024-05-15 | 59.42M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | 59.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 59.41M shares derived: average of 2 quarters · filed 2024-03-29 | 59.40M shares derived: average of 3 quarters · filed 2024-03-29 | 59.39M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 59.40M shares 10-Q · filed 2023-11-13 | 59.39M shares derived: average of 2 quarters · filed 2023-11-13 | 59.38M shares 10-Q · filed 2023-11-13 | 59.37M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 59.39M shares 10-Q · filed 2023-08-14 | 59.37M shares 10-Q · filed 2023-08-14 | 59.36M shares derived: average of 3 quarters · filed 2023-08-14 | 59.35M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 59.35M shares 10-Q · filed 2023-05-15 | 59.35M shares derived: average of 2 quarters · filed 2023-05-15 | 59.33M shares derived: average of 3 quarters · filed 2023-05-15 | 59.08M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 59.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 59.32M shares derived: average of 2 quarters · filed 2023-03-30 | 58.98M shares derived: average of 3 quarters · filed 2023-03-30 | 58.53M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 59.29M shares 10-Q · filed 2022-11-14 | 58.80M shares derived: average of 2 quarters · filed 2022-11-14 | 58.25M shares 10-Q · filed 2022-11-14 | 57.95M shares derived: average of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | 58.31M shares 10-Q · filed 2022-08-15 | 57.73M shares 10-Q · filed 2022-08-15 | 57.51M shares derived: average of 3 quarters · filed 2022-08-15 | 57.39M shares derived: average of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | 57.13M shares 10-Q · filed 2022-05-16 | 57.10M shares derived: average of 2 quarters · filed 2022-05-16 | 57.09M shares derived: average of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | 57.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 57.06M shares derived: average of 2 quarters · filed 2022-03-31 | 57.03M shares 10-K · filed 2022-03-31 | |
| 2020-09-30 | 57.05M shares 10-Q · filed 2021-11-15 | 57.01M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |